Clinical Trial Update: Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia [Phase 1, Phase 2]

View source ↗

Summary

Arrowhead Pharmaceuticals is investigating ARO-DIMERPA in adult participants with mixed hyperlipidemia in Phase 1/2 trials. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• ARO-DIMERPA

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Hyperlipidemia; Mixed | Phase 1, Phase 2 | Status: RECRUITING